canxpo

SOUTHAMPTON NY | AUG 1, 2024

Home        Register        Press        Join

REGISTER

7th Annual THC Expo

Little Beach Harvest Dispensary
Thur, Aug. 1st, 2024, 1-10pm
(Rain Date: Friday August 2nd)

“Connecting People & Opportunity”

Psychedelics & Cannabis in Chronic Disease Management: Integrative Medicine Approaches

SHIFTING TRENDS

As the landscape of medical treatment evolves, so does the focus of key conferences that drive these discussions. The 7th Annual THC EXPO event, titled “Psychedelics & Cannabis in Chronic Disease Management: Integrative Medicine Approaches,” reflects a strategic shift to align with the latest trends in medical cannabis and psychedelics.
2023: PAST PROGRAM GUIDE

Exhibit

Exhibiting at CanXpo provides you a cost-effective, status filled day summer pop-up that has the attention and focus to drive attention and interest to your service or products.

Apply to Exhibit

Sponsorships

We offer a variety of customized sponsorship opportunities for both local and non-local companies, as well as media partnerships. Increase visibility in a trend-setting marketplace.

Become a Sponsor

Speakers

Government Agencies, Entrepreneurs, CEO’s, and Angel Investors, use our platform to educate our audience and share their perspectives on market trends.

Learn More

The conference will bring together a diverse group of stakeholders, including:

Clinicians & Healers:

Exploring new integrative medicine approaches to improve patient outcomes.

Pharma & Biotech Representatives:

Discussing advancements and potential collaborations.

Investors & Legal Experts:

Navigating the evolving regulatory landscape and investment opportunities.

Manufacturers & Wellness Product Developers:

Showcasing innovative products and treatments.

The Shinnecock Sovereign Lands:

A Unique Venue hosting the event on the Shinnecock lands is particularly significant. The Shinnecock Nation’s lands are sovereign, which means they operate under their governance, independent of state laws.

2024 HEADLINE SPEAKERS

Public Support & Legislative Changes

Perception Shifts on use of psychedelics & medical cannabis in the U.S.

Clinical Trials

Once, relegated to the fringes of medical research, these substances are now at the forefront of groundbreaking studies and biohacking aimed at treating chronic diseases and mental health conditions.

Over 50 sites across the U.S. are conducting clinical trials on psychedelics for conditions such as depression and PTSD. Notably, the Cleveland Clinic has expanded its research, launching its first psilocybin trial to treat treatment-resistant depression.

Public Acceptance

Public acceptance is also on the rise, with approximately 69% of Americans considering the therapeutic potential of psychedelics for mental health issues at least once a year.

By providing a platform for experts to share their knowledge and innovations, the event seeks to inspire new collaborations and advancements in the field. This gathering of industry leaders, researchers, and practitioners underscores the vital role that integrative medicine and plant-based therapies play in the future of healthcare.

CanXpo Press & Past Conference Info

Blog Posts